TLP
GH icon

Tri Locum Partners’s Guardant Health GH Stock Holding History

Tri Locum Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-255,011
Closed -$5.98M – 71
2023
Q1 		$5.98M Buy
255,011
+124,563
+95% +$3.56M 1.82% 21
2022
Q4 		$3.55M Sell
130,448
-155,500
-54% -$7.12M 1.44% 25
2022
Q3 		$15.4M Buy
285,948
+93,640
+49% +$4.81M 4.22% 7
2022
Q2 		$7.76M Buy
+192,308
New +$9.53M 3.18% 12

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Tri Locum Partners's GH Position: Q2 2023 in Review

Tri Locum Partners sold out of Guardant Health (GH) in Q2 2023, closing a stake of 255,011 shares — an estimated $5.98M sold.

Tri Locum Partners first reported a position in GH in Q2 2022 and held it in 4 quarters. The position peaked at $15.4M in Q3 2022. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Tri Locum Partners reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Tri Locum Partners sold 255,011 Guardant Health shares in Q2 2023, an estimated $5.98M.
  • Tri Locum Partners first reported a position in Guardant Health in Q2 2022 and held it in 4 quarters.
  • Tri Locum Partners's Guardant Health position peaked at $15.4M in Q3 2022.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Tri Locum Partners's 13F filing for Q2 2023, filed 14 Aug 2023.